Company Filing History:
Years Active: 1990-1997
Title: **Innovator Spotlight: Michael D. Fiechtner**
Introduction
Michael D. Fiechtner, an accomplished inventor based in Highland Park, Illinois, has made significant contributions to the field of medical diagnostics. With a total of four patents to his name, Fiechtner is at the forefront of innovations that facilitate rapid testing for glycated hemoglobin, a crucial marker in diabetes management.
Latest Patents
Among his latest patents, Fiechtner has developed two innovative methods focused on the rapid determination of glycated hemoglobin. The first patent describes a continuous test employing a non-equilibrium affinity binding method, utilizing agarose beads derivatized with 3-aminophenylboronic acid to specifically bind glycated hemoglobin. This method is integrated into a sample processor card that efficiently mixes and separates the test solution from the solid phase before absorbance readings are taken. The test provides two absorbance readings: one immediately post-mixing and another after significant binding, allowing for accurate standardization with units expressible as a percentage of hemoglobin A1c. Additionally, stable glycated hemoglobin solutions for assay standards and the preparation method for these standards are included in his innovations.
Career Highlights
Fiechtner's career is prominently associated with Abbott Laboratories Corporation, a leading global healthcare company. His innovative approaches to medical diagnostics have played a pivotal role in advancing testing methodologies, particularly for diabetes care. His work in developing rapid testing solutions exemplifies his commitment to improving patient outcomes through scientific innovation.
Collaborations
Throughout his career, Fiechtner has collaborated with notable peers including John M. Ramp and Barbara J. England. These joint efforts have fostered an environment of creativity and expertise, driving forward the development of pivotal healthcare technologies.
Conclusion
Michael D. Fiechtner's contributions to medical diagnostics, especially in the realm of glycated hemoglobin testing, showcase the powerful impact of innovation in healthcare. His patented methodologies not only enhance testing efficiency but also underscore the importance of collaboration within the scientific community. As a key figure at Abbott Laboratories Corporation, Fiechtner continues to pave the way for future advancements in medical technology.